本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Anaptysbio Inc

55.20
+0.14000.25%
盤後55.200.00000.00%19:30 EDT
成交量:86.88萬
成交額:4,776.32萬
市值:16.34億
市盈率:-61.01
高:55.77
開:55.76
低:53.71
收:55.06
52周最高:73.30
52周最低:20.49
股本:2,960.85萬
流通股本:2,104.51萬
量比:2.22
換手率:4.13%
股息:- -
股息率:- -
每股收益(TTM):-0.9047
每股收益(LYR):-0.4601
淨資產收益率:-114.55%
總資產收益率:6.78%
市淨率:128.22
市盈率(LYR):-119.97

資料載入中...

2021/02/25

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/19

重要事件披露

8-K - Current report
2021/01/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2020/11/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/17

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/26

重要事件披露

8-K - Current report
2020/10/13

重要事件披露

8-K - Current report
2020/08/20

重要事件披露

8-K - Current report